Ciaran Manus Maguire
Research Fellow, CRANN

Publications and Further Research Outputs

Peer-Reviewed Publications

Kuznetsova VA, Visheratina AK, Ryan A, Martynenko IV, Loudon A, Maguire CM, Purcell-Milton F, Orlova AO, Baranov AV, Fedorov AV, Prina-Mello A, Volkov Y, Gun'Ko YK., Enantioselective cytotoxicity of ZnS:Mn quantum dots in A549 cells., Chirality, 2017, p403-408 Journal Article, 2017 DOI

Gerlach JQ, Maguire CM, KrÃŒger A, Joshi L, Prina-Mello A, Griffin MD., Urinary nanovesicles captured by lectins or antibodies demonstrate variations in size and surface glycosylation profile., Nanomedicine (London, England), 12, (11), 2017, p1217-1229 Journal Article, 2017 DOI

Ciarán M. Maguire, Katherine Sillence, Matthias Roesslein, Claire Hannell, Guillaume Suarez, Jean-Jacques Sauvain, Sonja Capracotta, Servane Contal, Sebastien Cambier, Naouale El Yamani, Maria Dusinska, Agnieszka Dybowska, Antje Vennemann, Laura Cooke, Andrea Haase, Andreas Luch, Martin Wiemann, Arno Gutleb, Rafi Korenstein, Michael Riediker, Peter Wick, Patrick Hole and Adriele Prina-Mello, Benchmark of Nanoparticle Tracking Analysis on Measuring Nanoparticle Sizing and Concentration, Journal of Micro and Nano-Manufacturing, 5, (4), 2017, p041002-1 - 041002-10 Journal Article, 2017 DOI URL

Spadavecchia J, Movia D, Moore C, Maguire CM, Moustaoui H, Casale S, Volkov Y, Prina-Mello A, Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies., International journal of nanomedicine, 11, 2016, p791-822 Journal Article, 2016 TARA - Full Text DOI

, Quantum dots; size dependent anticoagulant properties, British Society for Nanomedicine Early Career Researchers Meeting, 1, (2), 2016, p35--82 Journal Article, 2016

Staedler D, Passemard S, Magouroux T, Rogov A, Maguire CM, Mohamed BM, Schwung S, Rytz D, Justel T, Hwu S, Mugnier Y, Le Dantec R, Volkov Y, Gerber-Lemaire S, Prina-Mello A, Bonacina L, Wolf JP, Cellular uptake and biocompatibility of bismuth ferrite harmonic advanced nanoparticles, Nanomedicine, 11, (4), 2015, p815 - 824 Journal Article, 2015 URL DOI

Movia, D., Gerard, V., Maguire, C.M., Jain, N., Bell, A.P., Nicolosi, V., O'Neill, T., Scholz, D., Gun'ko, Y., Volkov, Y., Prina-Mello, A., A safe-by-design approach to the development of gold nanoboxes as carriers for internalization into cancer cells, Biomaterials, 35, (9), 2014, p2543-2557 Journal Article, 2014 DOI

Maguire, C.M., Mahfoud, O.K., Rakovich, T., (...), Gun'ko, Y., Volkov, Y. , Heparin conjugated quantum dots for in vitro imaging applications, Nanomedicine: Nanotechnology, Biology, and Medicine, 10, (8), 2014, p1853 - 1861 Journal Article, 2014 DOI URL URL

Hole P, Sillence K, Hannell C, Maguire CM, Roesslein M, Suarez G, Capracotta S, Magdolenova Z, Horev-Azaria L, Dybowska A, Cooke L, Haase A, Contal S, Manø S, Vennemann A, Sauvain JJ, Staunton KC, Anguissola S, Luch A, Dusinska M, Korenstein R, Gutleb AC, Wiemann M, Prina-Mello A, Riediker M, Wick P, Interlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA)., Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology, 15, 2013, p2101 Journal Article, 2013

Gerard VA, Maguire CM, Bazou D, Gun'ko YK, Folic acid modified gelatine coated quantum dots as potential reagents for in vitro cancer diagnostics., Journal of Nanobiotechnology, 9, (1), 2011, p50 Journal Article, 2011 TARA - Full Text DOI

Research Expertise


I am a highly motivated researcher with interests in all areas of science and technology, with a particular interest in nanomaterials and their applications. During the course of my PhD I have been involved in the optimisation and validation of nanoparticle characterisation techniques, as well as the development of novel therapeutics for blood coagulation disorders. I have worked as part of multidisciplinary teams with both academia and industry, along with carrying out my own self-motivated chemical and biological research. I also have a growing interest in regulatory affairs brought about through my engagement with industry partners. I am currently acting as a post-doctoral research fellow aiding in the screening and assessment of novel nanomedicine products and devices.


HAEMOSTASIS; High Content Screening; Nanoparticle Tracking Analysis; NANOPARTICLES; nanotoxicology; PHYSICOCHEMICAL CHARACTERISATION; Thrombosis and haemostasis



Royal Society of Chemistry 2008 – Present

British Society of Nanomedicine Acacadmic Memmber 2016 – Present